Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

E. Gabriela Chiorean, Sonal P. Sanghani, Marissa A. Schiel, Menggang Yu, Matthew Burns, Yan Tong, David T. Hinkle, Nicki Coleman, Bruce W. Robb, Julia K. Leblanc,

Cancer Chemotherapy and Pharmacology · 2012 · 17 citations · 22 references

Concepts

References

22